Moderna to build mRNA vaccine manufacturing plant in Victoria
Moderna has signed an agreement in principle with the Government of Australia to build a messenger RNA (mRNA) vaccine manufacturing plant in Victoria. According to ... Read More
US biotech company Moderna to build $500m mRNA facility in Africa
Moderna will invest up to $500 million to construct a messenger RNA facility (mRNA facility) in Africa with an aim to produce up to 500 ... Read More
Indian government approves use of Moderna’s Covid-19 Vaccine Moderna
US biotech company Moderna has been given emergency use authorization from the Indian government for its Covid-19 Vaccine Moderna (mRNA-1273) in adults aged 18 years ... Read More
Samsung Biologics to manufacture Moderna’s mRNA-1273 COVID-19 vaccine
Moderna has signed a manufacturing services and supply agreement with Samsung Biologics under which the latter will undertake large scale, commercial fill-finish manufacturing for the ... Read More
Moderna to supply 7m more doses of Covid-19 Vaccine Moderna to Philippines
Moderna has agreed to supply the Philippines with seven million additional doses of Covid-19 Vaccine Moderna, to take the confirmed order commitment to the Asian ... Read More
FDA grants emergency use authorization for Moderna Covid-19 vaccine
The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for Moderna's Covid-19 vaccine, mRNA-1273, marking a significant milestone in the global ... Read More
Moderna bags $1.5bn contract to supply mRNA-1273 Covid-19 vaccine to US govt
Moderna has bagged a deal worth up to $1.52 billion for the manufacturing and supply of 100 million doses of its mRNA-1273 vaccine candidate for ... Read More
COVID-19 vaccine trials : Research Centers of America begins enrollment of healthy volunteers
Research Centers of America (RCA), an independent research site in Broward County, Florida, said that it is currently holding COVID-19 vaccine trials, implemented under the ... Read More
Moderna, Rovi to collaborate on fill-finish manufacturing of mRNA-1273
Moderna and Laboratorios Farmacéuticos Rovi have entered into a collaboration for large-scale, commercial fill-finish manufacturing of mRNA-1273, the former's mRNA vaccine candidate against COVID-19, at ... Read More
Moderna completes enrollment for phase 2 trial of mRNA-1273
Moderna said that it has concluded enrollment for the two cohorts of the phase 2 study of its COVID-19 vaccine candidate mRNA-1273. According to the ... Read More